314 related articles for article (PubMed ID: 26938158)
1. Aspirin has limited ability to modulate shear-mediated platelet activation associated with elevated shear stress of ventricular assist devices.
Valerio L; Tran PL; Sheriff J; Brengle W; Ghosh R; Chiu WC; Redaelli A; Fiore GB; Pappalardo F; Bluestein D; Slepian MJ
Thromb Res; 2016 Apr; 140():110-117. PubMed ID: 26938158
[TBL] [Abstract][Full Text] [Related]
2. Routine clinical anti-platelet agents have limited efficacy in modulating hypershear-mediated platelet activation associated with mechanical circulatory support.
Valerio L; Sheriff J; Tran PL; Brengle W; Redaelli A; Fiore GB; Pappalardo F; Bluestein D; Slepian MJ
Thromb Res; 2018 Mar; 163():162-171. PubMed ID: 29428715
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy of in vitro and in vivo metabolized aspirin in the DeBakey ventricular assist device.
Sheriff J; Girdhar G; Chiu WC; Jesty J; Slepian MJ; Bluestein D
J Thromb Thrombolysis; 2014 May; 37(4):499-506. PubMed ID: 24043375
[TBL] [Abstract][Full Text] [Related]
4. Prothrombotic activity of cytokine-activated endothelial cells and shear-activated platelets in the setting of ventricular assist device support.
Apostoli A; Bianchi V; Bono N; Dimasi A; Ammann KR; Moiia YR; Montisci A; Sheriff J; Bluestein D; Fiore GB; Pappalardo F; Candiani G; Redaelli A; Slepian MJ; Consolo F
J Heart Lung Transplant; 2019 Jun; 38(6):658-667. PubMed ID: 30846234
[TBL] [Abstract][Full Text] [Related]
5. Circulatory loop design and components introduce artifacts impacting in vitro evaluation of ventricular assist device thrombogenicity: A call for caution.
Li M; Walk R; Roka-Moiia Y; Sheriff J; Bluestein D; Barth EJ; Slepian MJ
Artif Organs; 2020 Jun; 44(6):E226-E237. PubMed ID: 31876310
[TBL] [Abstract][Full Text] [Related]
6. Microfludic platforms for the evaluation of anti-platelet agent efficacy under hyper-shear conditions associated with ventricular assist devices.
Dimasi A; Rasponi M; Consolo F; Fiore GB; Bluestein D; Slepian MJ; Redaelli A
Med Eng Phys; 2017 Oct; 48():31-38. PubMed ID: 28869117
[TBL] [Abstract][Full Text] [Related]
7. Microfluidic approaches for the assessment of blood cell trauma: a focus on thrombotic risk in mechanical circulatory support devices.
Consolo F; Dimasi A; Rasponi M; Valerio L; Pappalardo F; Bluestein D; Slepian MJ; Fiore GB; Redaelli A
Int J Artif Organs; 2016 Jun; 39(4):184-93. PubMed ID: 27034318
[TBL] [Abstract][Full Text] [Related]
8. Effects of ticlopidine on von Willebrand factor-mediated shear-induced platelet activation and aggregation.
Goto S; Tamura N; Sakakibara M; Ikeda Y; Handa S
Platelets; 2001 Nov; 12(7):406-14. PubMed ID: 11674857
[TBL] [Abstract][Full Text] [Related]
9. Hemolysate-mediated platelet aggregation: an additional risk mechanism contributing to thrombosis of continuous flow ventricular assist devices.
Tran PL; Pietropaolo MG; Valerio L; Brengle W; Wong RK; Kazui T; Khalpey ZI; Redaelli A; Sheriff J; Bluestein D; Slepian MJ
Perfusion; 2016 Jul; 31(5):401-8. PubMed ID: 26590166
[TBL] [Abstract][Full Text] [Related]
10. Microfluidic emulation of mechanical circulatory support device shear-mediated platelet activation.
Dimasi A; Rasponi M; Sheriff J; Chiu WC; Bluestein D; Tran PL; Slepian MJ; Redaelli A
Biomed Microdevices; 2015 Dec; 17(6):117. PubMed ID: 26578003
[TBL] [Abstract][Full Text] [Related]
11. Platelet Activation via Shear Stress Exposure Induces a Differing Pattern of Biomarkers of Activation versus Biochemical Agonists.
Roka-Moiia Y; Walk R; Palomares DE; Ammann KR; Dimasi A; Italiano JE; Sheriff J; Bluestein D; Slepian MJ
Thromb Haemost; 2020 May; 120(5):776-792. PubMed ID: 32369849
[TBL] [Abstract][Full Text] [Related]
12. Reduced effect of aspirin on thrombus formation at high shear and disturbed laminar blood flow.
Barstad RM; Orvim U; Hamers MJ; Tjønnfjord GE; Brosstad FR; Sakariassen KS
Thromb Haemost; 1996 May; 75(5):827-32. PubMed ID: 8725731
[TBL] [Abstract][Full Text] [Related]
13. On-Chip Platelet Activation Assessment: Microfluidic Emulation of Shear Stress Profiles Induced by Mechanical Circulatory Support Devices.
Mencarini T; Bozzi S; Redaelli A
Methods Mol Biol; 2022; 2373():201-212. PubMed ID: 34520014
[TBL] [Abstract][Full Text] [Related]
14. Repetitive Hypershear Activates and Sensitizes Platelets in a Dose-Dependent Manner.
Sheriff J; Tran PL; Hutchinson M; DeCook T; Slepian MJ; Bluestein D; Jesty J
Artif Organs; 2016 Jun; 40(6):586-95. PubMed ID: 26527361
[TBL] [Abstract][Full Text] [Related]
15. Platelet adhesion emulation: A novel method for estimating the device thrombosis potential of a ventricular assist device.
Liu GM; Chen HB; Hou JF; Zhang Y; Hu SS
Int J Artif Organs; 2020 Apr; 43(4):252-257. PubMed ID: 31709882
[TBL] [Abstract][Full Text] [Related]
16. Normal platelet activation profile in patients with peripheral arterial disease on aspirin.
van Geffen JP; Kleinegris MC; Verdoold R; Baaten CC; Cosemans JM; Clemetson KJ; Ten Cate H; Roest M; de Laat B; Heemskerk JW
Thromb Res; 2015 Mar; 135(3):513-20. PubMed ID: 25600441
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of platelet functional changes and effects of anti-platelet agents on in vivo hemostasis under different gravity conditions.
Li S; Shi Q; Liu G; Zhang W; Wang Z; Wang Y; Dai K
J Appl Physiol (1985); 2010 May; 108(5):1241-9. PubMed ID: 20133435
[TBL] [Abstract][Full Text] [Related]
18. The platelet hammer: In vitro platelet activation under repetitive hypershear.
Sheriff J; Tran PL; Hutchinson M; DeCook T; Slepian MJ; Bluestein D; Jesty J
Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():262-5. PubMed ID: 26736250
[TBL] [Abstract][Full Text] [Related]
19. Initial experience with dual antiplatelet thromboprophylaxis using clopidogrel and aspirin in patients with mechanical aortic prostheses.
García-Rinaldi R; Carro-Pagán C; Schaff HV; McKellar SH; Thompson JL; Quiñones J; Rodríguez-Acosta JF
J Heart Valve Dis; 2009 Nov; 18(6):617-25; discussion 626. PubMed ID: 20099710
[TBL] [Abstract][Full Text] [Related]
20. Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in patients after recent ischemic stroke: for the Plavix Use for Treatment of Stroke (PLUTO-Stroke) trial.
Serebruany VL; Malinin AI; Ziai W; Pokov AN; Bhatt DL; Alberts MJ; Hanley DF
Stroke; 2005 Oct; 36(10):2289-92. PubMed ID: 16151033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
